Rosiglitazone

From WikiMD.org
Jump to navigation Jump to search

Rosiglitazone

Rosiglitazone (pronounced roh-si-glit-uh-zohn) is an antidiabetic drug in the thiazolidinedione class of drugs. It is marketed by the pharmaceutical company GlaxoSmithKline as a stand-alone drug or for use in combination with metformin or with sulfonylurea.

Etymology

The name "Rosiglitazone" is derived from parts of its chemical structure. "Ros" is short for rosaniline, a compound used in the synthesis of the drug. "Gli" is derived from glitazone, the class of drugs to which Rosiglitazone belongs.

Usage

Rosiglitazone is used to treat type 2 diabetes. It works by making the body's cells more sensitive to insulin, which helps the body use glucose more effectively.

Side Effects

Common side effects of Rosiglitazone include headache, muscle pain, and sore throat. Serious side effects can include heart failure and liver disease.

Related Terms

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski